Medical Health Screening Market Analysis: How The Industry Is Evolving Toward A $26.97 Billion Future

Medical Health Screening Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Medical Health Screening Market Forecast: What Value Will The Market Reach By 2030?

The medical health screening market has seen robust expansion in recent years. This market is expected to increase from $19.74 billion in 2025 to $21.06 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Factors contributing to its historical growth include a heightened focus on preventive healthcare, the proliferation of diagnostic laboratory networks, an increase in the prevalence of chronic diseases, enhanced availability of routine testing services, and the expansion of employer-backed health programs.

The medical health screening market size is projected to experience strong growth in the coming years. It is predicted to reach $26.97 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.4%. This expansion during the forecast period can be attributed to factors such as the increasing adoption of personalized medicine approaches, the rising integration of digital health platforms, the expansion of population-level screening initiatives, the growing demand for home-based testing services, and an increasing focus on early cancer detection. Major trends anticipated in this period include the increasing adoption of preventive health screening programs, the rising use of multi-parameter diagnostic panels, a growing demand for early disease detection services, the expansion of corporate and occupational health screening, and an enhanced focus on personalized screening protocols.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=95513459&type=smp&name=Medical%20Health%20Screening%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Medical Health Screening Market Industry Drivers: What’s Behind The Revenue Growth?

The increasing incidence of chronic diseases is anticipated to boost the growth of the medical health screening market in the future. Chronic diseases are defined as long-term health issues, such as diabetes, heart disease, and asthma, which typically endure for a year or more, necessitating continuous medical care or restricting daily activities. The rise in these conditions is attributable to sedentary lifestyles, as prolonged inactivity weakens overall body health and increases susceptibility to long-term medical issues. Medical health screening is crucial for chronic diseases because it enables the early detection of risk factors and symptoms, allowing for prompt intervention and management. This approach can prevent complications, enhance quality of life, and alleviate the overall burden associated with these persistent conditions. For instance, in April 2025, according to the International Diabetes Federation, a Belgium-based non-profit organization, as of today, 589 million adults aged 20–79 are living with diabetes worldwide, and this number is expected to rise to 853 million by 2050. Thus, the escalating prevalence of chronic diseases is propelling the expansion of the medical health screening market.

Medical Health Screening Market Segment Trends And Revenue Contributors

The medical health screening market covered in this report is segmented –

1) By Test Type: Routine Tests, Non-Routine Tests, Cancer Screening Tests, Specialty Tests, Other Test Types

2) By Sample Type: Blood, Urine, Saliva, Other Sample Types

3) By End User: Hospitals Or Clinics, Diagnostic Laboratories, Workplaces, Research Institutes, Other End Users

Subsegments:

1) By Routine Tests: Blood Pressure Monitoring, Blood Glucose Testing, Lipid Profile, Complete Blood Count (CBC), Urinalysis

2) By Non-Routine Tests: Genetic Testing, Hormonal Testing, Allergy Testing, Infectious Disease Testing

3) By Cancer Screening Tests: Mammography, Pap Smear Test, Colonoscopy, Prostate-Specific Antigen (PSA) Test, Low-Dose CT Scan For Lung Cancer

4) By Specialty Tests: Cardiovascular Screening, Neurological Screening, Pulmonary Function Tests, Bone Density Test

5) By Other Test Types: Wellness Tests, Executive Health Checkups, Prenatal Screening, Occupational Health Screening

#Medical Health Screening Market Growth Trends: What’s Shaping The Future Outlook?

Major companies operating in the medical health screening market are focusing on introducing innovative solutions, such as artificial intelligence-powered radiology informatics and cancer screening, to enhance early detection, improve diagnostic accuracy, and streamline clinical workflows. AI-enabled radiology informatics and cancer screening refer to the use of artificial intelligence technologies to analyze medical imaging data and identify potential signs of cancer or other abnormalities with greater speed and accuracy. For instance, in February 2025, DeepHealth, a US-based health informatics company, launched a new suite of AI-powered radiology informatics and cancer screening solutions powered by their cloud-native operating system, DeepHealth OS. This includes the Diagnostic Suite, a unified AI-driven diagnostic workspace, and advanced AI tools for lung, prostate, and brain health screening. These innovations aim to enhance clinical accuracy, streamline workflows, and improve operational efficiency across diverse healthcare settings.

Medical Health Screening Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc, Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc, DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc, Freenome Holdings Inc, Genova Diagnostics Inc, Cerba Healthcare SAS, DELFI Diagnostics Inc, Truvian Sciences Inc, ACM Medical Laboratory Inc, LabPlus, Sonic Healthcare Limited

View The Full Medical Health Screening Market Report:

https://thebusinessresearchcompany.com/report/medical-health-screening-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Medical Health Screening Market Regional Analysis And Top Geography

North America was the largest region in the medical health screening market in 2025. The regions covered in the medical health screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model